CUSIP 004890109COMMON STOCKACRVQ4 2025
24 filings · latest Nov 21, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 8.34M | $20.10M |
| 2 | Sands Capital Alternatives, LLC | 2.12M | $5.12M |
| 3 | Citadel Advisors LLC | 1.64M | $3.96M |
| 4 | Wellington Management Group LLP | 888.1K | $2.14M |
| 5 | Vanguard Group Inc | 698.9K | $1.68M |
| 6 | Renaissance Technologies LLC | 634.2K | $1.53M |
| 7 | Two Sigma Investments, LP | 585.1K | $1.41M |
| 8 | Marshall Wace, LLP | 496.1K | $1.20M |
| 9 |
| 4 | Jun 4, 2025 | Perceptive Advisors LLC | 13G/A | — | — | SEC |
| 5 | May 15, 2025 | Citadel Advisors LLC | 13G/A | 6.0% | 1.90M | SEC |
| 6 | May 1, 2025 | Perceptive Advisors LLC | 13G/A | 9.9% | 3.10M | SEC |
| 7 | Jul 10, 2024 | Chione Ltd | 13G/A | 12.5% | 3.85M | SEC |
| 8 | Jul 10, 2024 | Chione Ltd | 13G/A | 17.3% | 3.85M | SEC |
| 9 | Apr 15, 2024 | Perceptive Advisors LLC | 13G/A | 17.4% | 5.36M | SEC |
| 10 | Apr 11, 2024 | Ra Capital Management, L.P. | 13D/A | 27.1% | 8.36M | SEC |
See the full Schedule 13D/13G history for Acrivon Therapeutics Inc.
Unlock full history| Acorn Capital Advisors, LLC |
| 405.2K |
| $976.6K |
| 10 | Ubs Group AG | 348.5K | $840.0K |